A study from Indiana University School of Medicine shows that prescriptions for GLP-1 weight loss drugs jumped nearly 40-fold between 2017 and 2021, with many people now turning to options like semaglutide and tirzepatide
These resources discuss the evidence and limitations for specific topics
Decreased appetite was the most frequently reported AE in the FAERS database, including exenatide (n = 6,125, 58.61%), dulaglutide (n = 2,331, 48.09%), liraglutide (n = 1,174, 41.05%), semaglutide (n = 1,377, 47.40%), and tirzepatide (n = 550, 50.51%), with the exception that it is also one of the therapeutic effects of GLP-1 RAs, therefore, decreased appetite was analyzed only at the HLT level (Supplementary Table S2)
You could use a calendar app on your phone or a good old-fashioned paper calendarwhatever works for you
The important topic is how social stress induces temporary changes in the epigenetic network and whether gene expression might contribute to long-term socialbehavioural adaptations
Int Immunopharmacol (2020) 78:105985
)
